1. Home
  2. ORMP vs ANVS Comparison

ORMP vs ANVS Comparison

Compare ORMP & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • ANVS
  • Stock Information
  • Founded
  • ORMP 2002
  • ANVS 2008
  • Country
  • ORMP United States
  • ANVS United States
  • Employees
  • ORMP N/A
  • ANVS N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • ANVS Health Care
  • Exchange
  • ORMP Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • ORMP 90.7M
  • ANVS 92.6M
  • IPO Year
  • ORMP N/A
  • ANVS 2020
  • Fundamental
  • Price
  • ORMP $2.40
  • ANVS $2.73
  • Analyst Decision
  • ORMP Hold
  • ANVS Strong Buy
  • Analyst Count
  • ORMP 1
  • ANVS 6
  • Target Price
  • ORMP N/A
  • ANVS $31.40
  • AVG Volume (30 Days)
  • ORMP 493.3K
  • ANVS 621.3K
  • Earning Date
  • ORMP 03-05-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • ORMP N/A
  • ANVS N/A
  • EPS Growth
  • ORMP N/A
  • ANVS N/A
  • EPS
  • ORMP 0.11
  • ANVS N/A
  • Revenue
  • ORMP N/A
  • ANVS N/A
  • Revenue This Year
  • ORMP N/A
  • ANVS N/A
  • Revenue Next Year
  • ORMP N/A
  • ANVS N/A
  • P/E Ratio
  • ORMP $21.93
  • ANVS N/A
  • Revenue Growth
  • ORMP N/A
  • ANVS N/A
  • 52 Week Low
  • ORMP $2.00
  • ANVS $2.44
  • 52 Week High
  • ORMP $3.67
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 55.14
  • ANVS 23.71
  • Support Level
  • ORMP $2.16
  • ANVS $2.44
  • Resistance Level
  • ORMP $3.09
  • ANVS $5.50
  • Average True Range (ATR)
  • ORMP 0.15
  • ANVS 0.31
  • MACD
  • ORMP 0.03
  • ANVS -0.11
  • Stochastic Oscillator
  • ORMP 28.87
  • ANVS 11.28

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: